{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:36:15Z","timestamp":1791408975043,"version":"4.3.3"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T00:00:00Z","timestamp":1493251200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s00467-017-3677-5","type":"journal-article","created":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T08:36:36Z","timestamp":1493282196000},"page":"573-584","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":109,"title":["Immunology of idiopathic nephrotic syndrome"],"prefix":"10.1007","volume":"33","author":[{"given":"Manuela","family":"Colucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Corpetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Emma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Vivarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,27]]},"reference":[{"issue":"9384","key":"3677_CR1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","volume":"362","author":"AA Eddy","year":"2003","unstructured":"Eddy AA, Symons JM (2003) Nephrotic syndrome in childhood. Lancet 362(9384):629\u2013639","journal-title":"Lancet"},{"issue":"6","key":"3677_CR2","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jpeds.2009.12.020","volume":"156","author":"M Vivarelli","year":"2010","unstructured":"Vivarelli M, Moscaritolo E, Tsalkidis A, Massella L, Emma F (2010) Time for initial response to steroids is a major prognostic factor in idiopathic nephrotic syndrome. J Pediatr 156(6):965\u2013971","journal-title":"J Pediatr"},{"key":"3677_CR3","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05000516","author":"M Vivarelli","year":"2016","unstructured":"Vivarelli M, Massella L, Ruggiero B, Emma F (2016) Minimal change disease. Clin J Am Soc Nephrol. doi: 10.2215\/CJN.05000516","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"3677_CR4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nrneph.2014.216","volume":"11","author":"AB Fogo","year":"2015","unstructured":"Fogo AB (2015) Causes and pathogenesis of focal segmental glomerulosclerosis. Nat Rev Nephrol 11(2):76\u201387","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"3677_CR5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrneph.2016.195","volume":"13","author":"RJ Maas","year":"2017","unstructured":"Maas RJ, Wetzels JF (2017) Glomerular disease in 2016: New advances in the treatment of glomerular disease. Nat Rev Nephrol 13(2):65\u201366","journal-title":"Nat Rev Nephrol"},{"issue":"11","key":"3677_CR6","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/ndt\/gfv355","volume":"31","author":"S Lovric","year":"2016","unstructured":"Lovric S, Ashraf S, Tan W, Hildebrandt F (2016) Genetic testing in steroid-resistant nephrotic syndrome: when and how? Nephrol Dial Transplant 31(11):1802\u20131813","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"3677_CR7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00467-015-3082-x","volume":"31","author":"JC Davin","year":"2016","unstructured":"Davin JC (2016) The glomerular permeability factors in idiopathic nephrotic syndrome. Pediatr Nephrol 31(2):207\u2013215","journal-title":"Pediatr Nephrol"},{"key":"3677_CR8","doi-asserted-by":"crossref","first-page":"3765608","DOI":"10.1155\/2016\/3765608","volume":"2016","author":"E Konigshausen","year":"2016","unstructured":"Konigshausen E, Sellin L (2016) Circulating permeability factors in primary focal segmental glomerulosclerosis: a review of proposed candidates. Biomed Res Int 2016:3765608","journal-title":"Biomed Res Int"},{"issue":"7773","key":"3677_CR9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0140-6736(72)91734-5","volume":"2","author":"JR Hoyer","year":"1972","unstructured":"Hoyer JR, Vernier RL, Najarian JS, Raij L, Simmons RL, Michael AF (1972) Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet 2(7773):343\u2013348","journal-title":"Lancet"},{"issue":"2","key":"3677_CR10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0022-3476(79)80665-4","volume":"95","author":"SM Mauer","year":"1979","unstructured":"Mauer SM, Hellerstein S, Cohn RA, Sibley RK, Vernier RL (1979) Recurrence of steroid-responsive nephrotic syndrome after renal transplantation. J Pediatr 95(2):261\u2013264","journal-title":"J Pediatr"},{"issue":"5","key":"3677_CR11","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1056\/NEJM200102013440517","volume":"344","author":"MJ Kemper","year":"2001","unstructured":"Kemper MJ, Wolf G, Muller-Wiefel DE (2001) Transmission of glomerular permeability factor from a mother to her child. N Engl J Med 344(5):386\u2013387","journal-title":"N Engl J Med"},{"issue":"17","key":"3677_CR12","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1056\/NEJMc1202500","volume":"366","author":"L Gallon","year":"2012","unstructured":"Gallon L, Leventhal J, Skaro A, Kanwar Y, Alvarado A (2012) Resolution of recurrent focal segmental glomerulosclerosis after retransplantation. N Engl J Med 366(17):1648\u20131649","journal-title":"N Engl J Med"},{"issue":"1","key":"3677_CR13","first-page":"32","volume":"22","author":"SW Zimmerman","year":"1984","unstructured":"Zimmerman SW (1984) Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation. Clin Nephrol 22(1):32\u201338","journal-title":"Clin Nephrol"},{"issue":"6","key":"3677_CR14","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1681\/ASN.2012020133","volume":"24","author":"A Goldwich","year":"2013","unstructured":"Goldwich A, Burkard M, Olke M, Daniel C, Amann K, Hugo C, Kurts C, Steinkasserer A, Gessner A (2013) Podocytes are nonhematopoietic professional antigen-presenting cells. J Am Soc Nephrol 24(6):906\u2013916","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"3677_CR15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrneph.2015.162","volume":"11","author":"TJ Rabelink","year":"2015","unstructured":"Rabelink TJ, de Zeeuw D (2015) The glycocalyx\u2014linking albuminuria with renal and cardiovascular disease. Nat Rev Nephrol 11(11):667\u2013676","journal-title":"Nat Rev Nephrol"},{"issue":"11","key":"3677_CR16","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00006454-198911000-00004","volume":"8","author":"JC McDonald","year":"1989","unstructured":"McDonald JC, Moore DL, Quennec P (1989) Clinical and epidemiologic features of mumps meningoencephalitis and possible vaccine-related disease. Pediatr Infect Dis J 8(11):751\u2013755","journal-title":"Pediatr Infect Dis J"},{"key":"3677_CR17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13052-015-0123-9","volume":"41","author":"SN Uwaezuoke","year":"2015","unstructured":"Uwaezuoke SN (2015) Steroid-sensitive nephrotic syndrome in children: triggers of relapse and evolving hypotheses on pathogenesis. Ital J Pediatr 41:19","journal-title":"Ital J Pediatr"},{"issue":"1","key":"3677_CR18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2215\/CJN.01850310","volume":"6","author":"A Gulati","year":"2011","unstructured":"Gulati A, Sinha A, Sreenivas V, Math A, Hari P, Bagga A (2011) Daily corticosteroids reduce infection-associated relapses in frequently relapsing nephrotic syndrome: a randomized controlled trial. Clin J Am Soc Nephrol 6(1):63\u201369","journal-title":"Clin J Am Soc Nephrol"},{"issue":"33","key":"3677_CR19","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1016\/j.vaccine.2013.05.004","volume":"31","author":"N Yildiz","year":"2013","unstructured":"Yildiz N, Sever L, Kasapcopur O, Cullu F, Arisoy N, Caliskan S (2013) Hepatitis B virus vaccination in children with steroid sensitive nephrotic syndrome: immunogenicity and safety? Vaccine 31(33):3309\u20133312","journal-title":"Vaccine"},{"issue":"9382","key":"3677_CR20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(03)14072-X","volume":"362","author":"AS Abeyagunawardena","year":"2003","unstructured":"Abeyagunawardena AS, Goldblatt D, Andrews N, Trompeter RS (2003) Risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome. Lancet 362(9382):449\u2013450","journal-title":"Lancet"},{"issue":"4","key":"3677_CR21","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1651-2227.2007.00154.x","volume":"96","author":"ME Salsano","year":"2007","unstructured":"Salsano ME, Graziano L, Luongo I, Pilla P, Giordano M, Lama G (2007) Atopy in childhood idiopathic nephrotic syndrome. Acta Paediatr 96(4):561\u2013566","journal-title":"Acta Paediatr"},{"issue":"7880","key":"3677_CR22","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","volume":"2","author":"RJ Shalhoub","year":"1974","unstructured":"Shalhoub RJ (1974) Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 2(7880):556\u2013560","journal-title":"Lancet"},{"issue":"1","key":"3677_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00011-013-0672-6","volume":"63","author":"F Pereira Wde","year":"2014","unstructured":"Pereira Wde F, Brito-Melo GE, Guimaraes FT, Carvalho TG, Mateo EC, Simoes e Silva AC (2014) The role of the immune system in idiopathic nephrotic syndrome: a review of clinical and experimental studies. Inflamm Res 63(1):1\u201312","journal-title":"Inflamm Res"},{"issue":"4","key":"3677_CR24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00281-013-0415-3","volume":"36","author":"D Sahali","year":"2014","unstructured":"Sahali D, Sendeyo K, Mangier M, Audard V, Zhang SY, Lang P, Ollero M, Pawlak A (2014) Immunopathogenesis of idiopathic nephrotic syndrome with relapse. Semin Immunopathol 36(4):421\u2013429","journal-title":"Semin Immunopathol"},{"issue":"3","key":"3677_CR25","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1681\/ASN.2011030304","volume":"23","author":"WG Couser","year":"2012","unstructured":"Couser WG (2012) Basic and translational concepts of immune-mediated glomerular diseases. J Am Soc Nephrol 23(3):381\u2013399","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"3677_CR26","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1053\/ajkd.2002.32769","volume":"39","author":"G Lama","year":"2002","unstructured":"Lama G, Luongo I, Tirino G, Borriello A, Carangio C, Salsano ME (2002) T-lymphocyte populations and cytokines in childhood nephrotic syndrome. Am J Kidney Dis 39(5):958\u2013965","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"3677_CR27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000085357","volume":"25","author":"MJ Kemper","year":"2005","unstructured":"Kemper MJ, Zepf K, Klaassen I, Link A, Muller-Wiefel DE (2005) Changes of lymphocyte populations in pediatric steroid-sensitive nephrotic syndrome are more pronounced in remission than in relapse. Am J Nephrol 25(2):132\u2013137","journal-title":"Am J Nephrol"},{"issue":"8","key":"3677_CR28","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00467-008-0793-2","volume":"23","author":"H Lapillonne","year":"2008","unstructured":"Lapillonne H, Leclerc A, Ulinski T, Balu L, Garnier A, Dereuddre-Bosquet N, Watier H, Schlageter MH, Deschenes G (2008) Stem cell mobilization in idiopathic steroid-sensitive nephrotic syndrome. Pediatr Nephrol 23(8):1251\u20131256","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"3677_CR29","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1046\/j.1523-1755.2001.059003975.x","volume":"59","author":"Y Wang","year":"2001","unstructured":"Wang Y, Wang Y, Feng X, Bao S, Yi S, Kairaitis L, Tay YC, Rangan GK, Harris DC (2001) Depletion of CD4(+) T cells aggravates glomerular and interstitial injury in murine adriamycin nephropathy. Kidney Int 59(3):975\u2013984","journal-title":"Kidney Int"},{"issue":"3","key":"3677_CR30","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1681\/ASN.V103529","volume":"10","author":"HK Yap","year":"1999","unstructured":"Yap HK, Cheung W, Murugasu B, Sim SK, Seah CC, Jordan SC (1999) Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse. J Am Soc Nephrol 10(3):529\u2013537","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"3677_CR31","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00467-006-0026-5","volume":"21","author":"CE Araya","year":"2006","unstructured":"Araya CE, Wasserfall CH, Brusko TM, Mu W, Segal MS, Johnson RJ, Garin EH (2006) A case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndrome. Pediatr Nephrol 21(5):603\u2013610","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"3677_CR32","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00467-009-1194-x","volume":"24","author":"XS Shao","year":"2009","unstructured":"Shao XS, Yang XQ, Zhao XD, Li Q, Xie YY, Wang XG, Wang M, Zhang W (2009) The prevalence of Th17 cells and FOXP3 regulate T cells (Treg) in children with primary nephrotic syndrome. Pediatr Nephrol 24(9):1683\u20131690","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"3677_CR33","first-page":"294","volume":"1","author":"YM Wang","year":"2008","unstructured":"Wang YM, Hu M, Wang Y, Polhill T, Zhang GY, Wang Y, Lee VW, Harris DC, Alexander SI (2008) Regulatory T cells in renal disease. Int J Clin Exp Med 1(4):294\u2013304","journal-title":"Int J Clin Exp Med"},{"issue":"6","key":"3677_CR34","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00467-009-1119-8","volume":"24","author":"Y Hashimura","year":"2009","unstructured":"Hashimura Y, Nozu K, Kanegane H, Miyawaki T, Hayakawa A, Yoshikawa N, Nakanishi K, Takemoto M, Iijima K, Matsuo M (2009) Minimal change nephrotic syndrome associated with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Pediatr Nephrol 24(6):1181\u20131186","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"3677_CR35","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/cei.12675","volume":"183","author":"R Bertelli","year":"2016","unstructured":"Bertelli R, Bonanni A, Di Donato A, Cioni M, Ravani P, Ghiggeri GM (2016) Regulatory T cells and minimal change nephropathy: in the midst of a complex network. Clin Exp Immunol 183(2):166\u2013174","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"3677_CR36","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1681\/ASN.2006121346","volume":"18","author":"AL Sellier-Leclerc","year":"2007","unstructured":"Sellier-Leclerc AL, Duval A, Riveron S, Macher MA, Deschenes G, Loirat C, Verpont MC, Peuchmaur M, Ronco P, Monteiro RC, Haddad E (2007) A humanized mouse model of idiopathic nephrotic syndrome suggests a pathogenic role for immature cells. J Am Soc Nephrol 18(10):2732\u20132739","journal-title":"J Am Soc Nephrol"},{"key":"3677_CR37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.0105-2896.2004.0109.x","volume":"197","author":"R Carsetti","year":"2004","unstructured":"Carsetti R, Rosado MM, Wardmann H (2004) Peripheral development of B cells in mouse and man. Immunol Rev 197:179\u2013191","journal-title":"Immunol Rev"},{"issue":"1","key":"3677_CR38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2215\/CJN.09430915","volume":"11","author":"W Hoffman","year":"2016","unstructured":"Hoffman W, Lakkis FG, Chalasani G (2016) B Cells, Antibodies, and more. Clin J Am Soc Nephrol 11(1):137\u2013154","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"3677_CR39","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1007\/s00467-004-1434-z","volume":"19","author":"K Benz","year":"2004","unstructured":"Benz K, Dotsch J, Rascher W, Stachel D (2004) Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy. Pediatr Nephrol 19(7):794\u2013797","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"3677_CR40","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2215\/CJN.08500815","volume":"11","author":"P Ravani","year":"2016","unstructured":"Ravani P, Bonanni A, Rossi R, Caridi G, Ghiggeri GM (2016) Anti-CD20 antibodies for idiopathic nephrotic syndrome in children. Clin J Am Soc Nephrol 11(4):710\u2013720","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 1","key":"3677_CR41","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/ar3908","volume":"15","author":"MJ Leandro","year":"2013","unstructured":"Leandro MJ (2013) B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies. Arthritis Res Ther 15[Suppl 1]:S3","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"3677_CR42","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1073\/pnas.1001074107","volume":"107","author":"H Huang","year":"2010","unstructured":"Huang H, Benoist C, Mathis D (2010) Rituximab specifically depletes short-lived autoreactive plasma cells in a mouse model of inflammatory arthritis. Proc Natl Acad Sci USA 107(10):4658\u20134663","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"3677_CR43","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3390\/cancers7010305","volume":"7","author":"J Worch","year":"2015","unstructured":"Worch J, Makarova O, Burkhardt B (2015) Immunreconstitution and infectious complications after rituximab treatment in children and adolescents: what do we know and what can we learn from adults? Cancers (Basel) 7(1):305\u2013328","journal-title":"Cancers (Basel)"},{"issue":"9","key":"3677_CR44","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1681\/ASN.V991709","volume":"9","author":"J Dantal","year":"1998","unstructured":"Dantal J, Godfrin Y, Koll R, Perretto S, Naulet J, Bouhours JF, Soulillou JP (1998) Antihuman immunoglobulin affinity immunoadsorption strongly decreases proteinuria in patients with relapsing nephrotic syndrome. J Am Soc Nephrol 9(9):1709\u20131715","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"3677_CR45","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00467-001-0817-7","volume":"17","author":"MJ Kemper","year":"2002","unstructured":"Kemper MJ, Altrogge H, Ganschow R, Muller-Wiefel DE (2002) Serum levels of immunoglobulins and IgG subclasses in steroid sensitive nephrotic syndrome. Pediatr Nephrol 17(6):413\u2013417","journal-title":"Pediatr Nephrol"},{"issue":"256","key":"3677_CR46","doi-asserted-by":"crossref","first-page":"256ra136","DOI":"10.1126\/scitranslmed.3008538","volume":"6","author":"M Delville","year":"2014","unstructured":"Delville M, Sigdel TK, Wei C, Li J, Hsieh SC, Fornoni A, Burke GW, Bruneval P, Naesens M, Jackson A, Alachkar N, Canaud G, Legendre C, Anglicheau D, Reiser J, Sarwal MM (2014) A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation. Sci Transl Med 6(256):256ra136","journal-title":"Sci Transl Med"},{"issue":"4","key":"3677_CR47","doi-asserted-by":"crossref","first-page":"242","DOI":"10.5414\/CNP60242","volume":"60","author":"MJ Kemper","year":"2003","unstructured":"Kemper MJ, Meyer-Jark T, Lilova M, Muller-Wiefel DE (2003) Combined T- and B-cell activation in childhood steroid-sensitive nephrotic syndrome. Clin Nephrol 60(4):242\u2013247","journal-title":"Clin Nephrol"},{"issue":"12","key":"3677_CR48","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1007\/s00467-014-2860-1","volume":"29","author":"C Dossier","year":"2014","unstructured":"Dossier C, Sellier-Leclerc AL, Rousseau A, Michel Y, Gautheret-Dejean A, Englender M, Madhi F, Charbit M, Ulinski T, Simon T, Jacqz-Aigrain E, Deschenes G (2014) Prevalence of herpesviruses at onset of idiopathic nephrotic syndrome. Pediatr Nephrol 29(12):2325\u20132331","journal-title":"Pediatr Nephrol"},{"issue":"7","key":"3677_CR49","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1681\/ASN.2014030247","volume":"26","author":"RA Gbadegesin","year":"2015","unstructured":"Gbadegesin RA, Adeyemo A, Webb NJ, Greenbaum LA, Abeyagunawardena A, Thalgahagoda S, Kale A, Gipson D, Srivastava T, Lin JJ, Chand D, Hunley TE, Brophy PD, Bagga A, Sinha A, Rheault MN, Ghali J, Nicholls K, Abraham E, Janjua HS, Omoloja A, Barletta GM, Cai Y, Milford DD, O\u2019Brien C, Awan A, Belostotsky V, Smoyer WE, Homstad A, Hall G, Wu G, Nagaraj S, Wigfall D, Foreman J, Winn MP, Mid-West Pediatric Nephrology C (2015) HLA-DQA1 and PLCG2 are candidate risk loci for childhood-onset steroid-sensitive nephrotic syndrome. J Am Soc Nephrol 26(7):1701\u20131710","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"3677_CR50","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00467-010-1465-6","volume":"25","author":"AL Sellier-Leclerc","year":"2010","unstructured":"Sellier-Leclerc AL, Macher MA, Loirat C, Guerin V, Watier H, Peuchmaur M, Baudouin V, Deschenes G (2010) Rituximab efficiency in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol 25(6):1109\u20131115","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"3677_CR51","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1681\/ASN.2015050523","volume":"27","author":"M Colucci","year":"2016","unstructured":"Colucci M, Carsetti R, Cascioli S, Casiraghi F, Perna A, Rava L, Ruggiero B, Emma F, Vivarelli M (2016) B cell reconstitution after rituximab treatment in idiopathic nephrotic syndrome. J Am Soc Nephrol 27(6):1811\u20131822","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"3677_CR52","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/ndt\/gfr405","volume":"27","author":"AL Sellier-Leclerc","year":"2012","unstructured":"Sellier-Leclerc AL, Baudouin V, Kwon T, Macher MA, Guerin V, Lapillonne H, Deschenes G, Ulinski T (2012) Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood\u2014follow-up after CD19 recovery. Nephrol Dial Transplant 27(3):1083\u20131089","journal-title":"Nephrol Dial Transplant"},{"issue":"85","key":"3677_CR53","doi-asserted-by":"crossref","first-page":"85ra46","DOI":"10.1126\/scitranslmed.3002231","volume":"3","author":"A Fornoni","year":"2011","unstructured":"Fornoni A, Sageshima J, Wei C, Merscher-Gomez S, Aguillon-Prada R, Jauregui AN, Li J, Mattiazzi A, Ciancio G, Chen L, Zilleruelo G, Abitbol C, Chandar J, Seeherunvong W, Ricordi C, Ikehata M, Rastaldi MP, Reiser J, Burke GW 3rd (2011) Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med 3(85):85ra46","journal-title":"Sci Transl Med"},{"issue":"4","key":"3677_CR54","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1681\/ASN.2013040363","volume":"25","author":"M Tasaki","year":"2014","unstructured":"Tasaki M, Shimizu A, Hanekamp I, Torabi R, Villani V, Yamada K (2014) Rituximab treatment prevents the early development of proteinuria following pig-to-baboon xeno-kidney transplantation. J Am Soc Nephrol 25(4):737\u2013744","journal-title":"J Am Soc Nephrol"},{"issue":"13","key":"3677_CR55","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMc1308488","volume":"370","author":"B Basu","year":"2014","unstructured":"Basu B (2014) Ofatumumab for rituximab-resistant nephrotic syndrome. N Engl J Med 370(13):1268\u20131270","journal-title":"N Engl J Med"},{"issue":"19","key":"3677_CR56","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1182\/blood-2011-09-377341","volume":"118","author":"A Schuh","year":"2011","unstructured":"Schuh A (2011) Anti-CD20: tales of identical twins? Blood 118(19):5066\u20135067","journal-title":"Blood"},{"issue":"3","key":"3677_CR57","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2215\/CJN.04121206","volume":"2","author":"L Barisoni","year":"2007","unstructured":"Barisoni L, Schnaper HW, Kopp JB (2007) A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. Clin J Am Soc Nephrol 2(3):529\u2013542","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"3677_CR58","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1681\/ASN.2007040395","volume":"19","author":"MC Banas","year":"2008","unstructured":"Banas MC, Banas B, Hudkins KL, Wietecha TA, Iyoda M, Bock E, Hauser P, Pippin JW, Shankland SJ, Smith KD, Stoelcker B, Liu G, Grone HJ, Kramer BK, Alpers CE (2008) TLR4 links podocytes with the innate immune system to mediate glomerular injury. J Am Soc Nephrol 19(4):704\u2013713","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"3677_CR59","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/ndt\/gfr271","volume":"27","author":"M Shimada","year":"2012","unstructured":"Shimada M, Ishimoto T, Lee PY, Lanaspa MA, Rivard CJ, Roncal-Jimenez CA, Wymer DT, Yamabe H, Mathieson PW, Saleem MA, Garin EH, Johnson RJ (2012) Toll-like receptor 3 ligands induce CD80 expression in human podocytes via an NF-nB-dependent pathway. Nephrol Dial Transplant 27(1):81\u201389","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"3677_CR60","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1073\/pnas.0711515105","volume":"105","author":"S Akilesh","year":"2008","unstructured":"Akilesh S, Huber TB, Wu H, Wang G, Hartleben B, Kopp JB, Miner JH, Roopenian DC, Unanue ER, Shaw AS (2008) Podocytes use FcRn to clear IgG from the glomerular basement membrane. Proc Natl Acad Sci USA 105(3):967\u2013972","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"3677_CR61","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1097\/01.ASN.0000136312.46464.33","volume":"15","author":"J Reiser","year":"2004","unstructured":"Reiser J, Mundel P (2004) Danger signaling by glomerular podocytes defines a novel function of inducible B7-1 in the pathogenesis of nephrotic syndrome. J Am Soc Nephrol 15(9):2246\u20132248","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"3677_CR62","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.4049\/jimmunol.168.12.6244","volume":"168","author":"TB Huber","year":"2002","unstructured":"Huber TB, Reinhardt HC, Exner M, Burger JA, Kerjaschki D, Saleem MA, Pavenstadt H (2002) Expression of functional CCR and CXCR chemokine receptors in podocytes. J Immunol 168(12):6244\u20136252","journal-title":"J Immunol"},{"issue":"1","key":"3677_CR63","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00441-011-1169-7","volume":"347","author":"HS Lee","year":"2012","unstructured":"Lee HS (2012) Mechanisms and consequences of TGF-ss overexpression by podocytes in progressive podocyte disease. Cell Tissue Res 347(1):129\u2013140","journal-title":"Cell Tissue Res"},{"issue":"6","key":"3677_CR64","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/sj.ki.5001655","volume":"70","author":"CY Xing","year":"2006","unstructured":"Xing CY, Saleem MA, Coward RJ, Ni L, Witherden IR, Mathieson PW (2006) Direct effects of dexamethasone on human podocytes. Kidney Int 70(6):1038\u20131045","journal-title":"Kidney Int"},{"issue":"2","key":"3677_CR65","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1681\/ASN.2007080836","volume":"20","author":"EH Garin","year":"2009","unstructured":"Garin EH, Diaz LN, Mu W, Wasserfall C, Araya C, Segal M, Johnson RJ (2009) Urinary CD80 excretion increases in idiopathic minimal-change disease. J Am Soc Nephrol 20(2):260\u2013266","journal-title":"J Am Soc Nephrol"},{"issue":"25","key":"3677_CR66","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa1304572","volume":"369","author":"CC Yu","year":"2013","unstructured":"Yu CC, Fornoni A, Weins A, Hakroush S, Maiguel D, Sageshima J, Chen L, Ciancio G, Faridi MH, Behr D, Campbell KN, Chang JM, Chen HC, Oh J, Faul C, Arnaout MA, Fiorina P, Gupta V, Greka A, Burke GW 3rd, Mundel P (2013) Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med 369(25):2416\u20132423","journal-title":"N Engl J Med"},{"issue":"5","key":"3677_CR67","doi-asserted-by":"crossref","first-page":"F335","DOI":"10.1152\/ajprenal.00510.2015","volume":"310","author":"R Novelli","year":"2016","unstructured":"Novelli R, Gagliardini E, Ruggiero B, Benigni A, Remuzzi G (2016) Any value of podocyte B7-1 as a biomarker in human MCD and FSGS? Am J Physiol Ren Physiol 310(5):F335\u2013F341","journal-title":"Am J Physiol Ren Physiol"},{"issue":"6","key":"3677_CR68","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/biof.62","volume":"35","author":"A Chatzigeorgiou","year":"2009","unstructured":"Chatzigeorgiou A, Lyberi M, Chatzilymperis G, Nezos A, Kamper E (2009) CD40\/CD40L signaling and its implication in health and disease. Biofactors 35(6):474\u2013483","journal-title":"Biofactors"},{"issue":"9","key":"3677_CR69","first-page":"115","volume":"3","author":"S Beaudreuil","year":"2015","unstructured":"Beaudreuil S, Lorenzo HK, Durrbach A (2015) The anti-CD40 auto-antibody: a biomarker or a factor for the permeability of recurrent focal segmental glomerulosclerosis? Ann Transl Med 3(9):115","journal-title":"Ann Transl Med"},{"issue":"11","key":"3677_CR70","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1681\/ASN.2007080940","volume":"19","author":"R Lennon","year":"2008","unstructured":"Lennon R, Singh A, Welsh GI, Coward RJ, Satchell S, Ni L, Mathieson PW, Bakker WW, Saleem MA (2008) Hemopexin induces nephrin-dependent reorganization of the actin cytoskeleton in podocytes. J Am Soc Nephrol 19(11):2140\u20132149","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"3677_CR71","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1007\/s00467-005-1936-3","volume":"20","author":"WW Bakker","year":"2005","unstructured":"Bakker WW, van Dael CM, Pierik LJ, van Wijk JA, Nauta J, Borghuis T, Kapojos JJ (2005) Altered activity of plasma hemopexin in patients with minimal change disease in relapse. Pediatr Nephrol 20(10):1410\u20131415","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"3677_CR72","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.2411","volume":"17","author":"C Wei","year":"2011","unstructured":"Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, Maiguel D, Karumanchi SA, Yap HK, Saleem M, Zhang Q, Nikolic B, Chaudhuri A, Daftarian P, Salido E, Torres A, Salifu M, Sarwal MM, Schaefer F, Morath C, Schwenger V, Zeier M, Gupta V, Roth D, Rastaldi MP, Burke G, Ruiz P, Reiser J (2011) Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 17(8):952\u2013960","journal-title":"Nat Med"},{"issue":"1","key":"3677_CR73","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nm.4242","volume":"23","author":"E Hahm","year":"2017","unstructured":"Hahm E, Wei C, Fernandez I, Li J, Tardi NJ, Tracy M, Wadhwani S, Cao Y, Peev V, Zloza A, Lusciks J, Hayek SS, O\u2019Connor C, Bitzer M, Gupta V, Sever S, Sykes DB, Scadden DT, Reiser J (2017) Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease. Nat Med 23(1):100\u2013106","journal-title":"Nat Med"},{"key":"3677_CR74","doi-asserted-by":"crossref","first-page":"2068691","DOI":"10.1155\/2016\/2068691","volume":"2016","author":"A Kronbichler","year":"2016","unstructured":"Kronbichler A, Saleem MA, Meijers B, Shin JI (2016) Soluble urokinase receptors in focal segmental glomerulosclerosis: a review on the scientific point of view. J Immunol Res 2016:2068691","journal-title":"J Immunol Res"},{"key":"3677_CR75","doi-asserted-by":"crossref","first-page":"714964","DOI":"10.1155\/2015\/714964","volume":"2015","author":"VJ Savin","year":"2015","unstructured":"Savin VJ, Sharma M, Zhou J, Gennochi D, Fields T, Sharma R, McCarthy ET, Srivastava T, Domen J, Tormo A, Gauchat JF (2015) Renal and hematological effects of CLCF-1, a B-cell-stimulating cytokine of the IL-6 family. J Immunol Res 2015:714964","journal-title":"J Immunol Res"},{"issue":"1","key":"3677_CR76","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nm.2261","volume":"17","author":"LC Clement","year":"2011","unstructured":"Clement LC, Avila-Casado C, Mace C, Soria E, Bakker WW, Kersten S, Chugh SS (2011) Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat Med 17(1):117\u2013122","journal-title":"Nat Med"},{"issue":"4","key":"3677_CR77","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/archdischild-2015-308924","volume":"101","author":"N Larkins","year":"2016","unstructured":"Larkins N, Kim S, Craig J, Hodson E (2016) Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children. Arch Dis Child 101(4):404\u2013408","journal-title":"Arch Dis Child"},{"issue":"9950","key":"3677_CR78","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0140-6736(14)60541-9","volume":"384","author":"K Iijima","year":"2014","unstructured":"Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, Miura K, Aya K, Nakanishi K, Ohtomo Y, Takahashi S, Tanaka R, Kaito H, Nakamura H, Ishikura K, Ito S, Ohashi Y, Rituximab for Childhood-onset Refractory Nephrotic Syndrome Study G (2014) Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 384(9950):1273\u20131281","journal-title":"Lancet"},{"issue":"9","key":"3677_CR79","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1681\/ASN.2014080799","volume":"26","author":"P Ravani","year":"2015","unstructured":"Ravani P, Rossi R, Bonanni A, Quinn RR, Sica F, Bodria M, Pasini A, Montini G, Edefonti A, Belingheri M, De Giovanni D, Barbano G, Degl\u2019Innocenti L, Scolari F, Murer L, Reiser J, Fornoni A, Ghiggeri GM (2015) Rituximab in children with steroid-dependent nephrotic syndrome: a multicenter, open-label, noninferiority, randomized controlled trial. J Am Soc Nephrol 26(9):2259\u20132266","journal-title":"J Am Soc Nephrol"},{"key":"3677_CR80","doi-asserted-by":"crossref","unstructured":"Ruggenenti P, Ruggiero B, Cravedi P, Vivarelli M, Massella L, Marasa M, Chianca A, Rubis N, Ene-Iordache B, Rudnicki M, Pollastro RM, Capasso G, Pisani A, Pennesi M, Emma F, Remuzzi G, Rituximab in Nephrotic Syndrome of Steroid-Dependent or Frequently Relapsing Minimal Change Disease Or Focal Segmental Glomerulosclerosis Study (NEMO) Study Group (2014) Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome. J Am Soc Nephrol 25(4):850\u2013863","DOI":"10.1681\/ASN.2013030251"},{"issue":"1","key":"3677_CR81","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00467-016-3498-y","volume":"32","author":"M Vivarelli","year":"2017","unstructured":"Vivarelli M, Colucci M, Bonanni A, Verzani M, Serafinelli J, Emma F, Ghiggeri G (2017) Ofatumumab in two pediatric nephrotic syndrome patients allergic to rituximab. Pediatr Nephrol 32(1):181\u2013184","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"3677_CR82","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","volume":"335","author":"AE Coutinho","year":"2011","unstructured":"Coutinho AE, Chapman KE (2011) The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol 335(1):2\u201313","journal-title":"Mol Cell Endocrinol"},{"issue":"12","key":"3677_CR83","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.7326\/0003-4819-119-12-199312150-00007","volume":"119","author":"DT Boumpas","year":"1993","unstructured":"Boumpas DT, Chrousos GP, Wilder RL, Cupps TR, Balow JE (1993) Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med 119(12):1198\u20131208","journal-title":"Ann Intern Med"},{"issue":"1","key":"3677_CR84","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00018-005-5390-y","volume":"63","author":"MJ Herold","year":"2006","unstructured":"Herold MJ, McPherson KG, Reichardt HM (2006) Glucocorticoids in T cell apoptosis and function. Cell Mol Life Sci 63(1):60\u201372","journal-title":"Cell Mol Life Sci"},{"issue":"5234","key":"3677_CR85","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1126\/science.270.5234.286","volume":"270","author":"N Auphan","year":"1995","unstructured":"Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M (1995) Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270(5234):286\u2013290","journal-title":"Science"},{"key":"3677_CR86","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cytogfr.2016.05.002","volume":"31","author":"J Banuelos","year":"2016","unstructured":"Banuelos J, Lu NZ (2016) A gradient of glucocorticoid sensitivity among helper T cell cytokines. Cytokine Growth Factor Rev 31:27\u201335","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"3677_CR87","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4049\/jimmunol.0802046","volume":"183","author":"C Luther","year":"2009","unstructured":"Luther C, Adamopoulou E, Stoeckle C, Brucklacher-Waldert V, Rosenkranz D, Stoltze L, Lauer S, Poeschel S, Melms A, Tolosa E (2009) Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients. J Immunol 183(2):841\u2013848","journal-title":"J Immunol"},{"issue":"9","key":"3677_CR88","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1681\/ASN.2014050468","volume":"26","author":"L Li","year":"2015","unstructured":"Li L, Zhang T, Diao W, Jin F, Shi L, Meng J, Liu H, Zhang J, Zeng CH, Zhang MC, Liang S, Liu Y, Zhang CY, Liu Z, Zen K (2015) Role of myeloid-derived suppressor cells in glucocorticoid-mediated amelioration of FSGS. J Am Soc Nephrol 26(9):2183\u20132197","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"3677_CR89","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1177\/153537020222700907","volume":"227","author":"D Lill-Elghanian","year":"2002","unstructured":"Lill-Elghanian D, Schwartz K, King L, Fraker P (2002) Glucocorticoid-induced apoptosis in early B cells from human bone marrow. Exp Biol Med (Maywood) 227(9):763\u2013770","journal-title":"Exp Biol Med (Maywood)"},{"issue":"7","key":"3677_CR90","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1681\/ASN.2015070781","volume":"27","author":"O Thaunat","year":"2016","unstructured":"Thaunat O, Koenig A, Leibler C, Grimbert P (2016) Effect of immunosuppressive drugs on humoral allosensitization after kidney transplant. J Am Soc Nephrol 27(7):1890\u20131900","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"3677_CR91","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1172\/JCI111757","volume":"75","author":"TR Cupps","year":"1985","unstructured":"Cupps TR, Gerrard TL, Falkoff RJ, Whalen G, Fauci AS (1985) Effects of in vitro corticosteroids on B cell activation, proliferation, and differentiation. J Clin Invest 75(2):754\u2013761","journal-title":"J Clin Invest"},{"issue":"1","key":"3677_CR92","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/ndt\/gfq617","volume":"26","author":"E Schonenberger","year":"2011","unstructured":"Schonenberger E, Ehrich JH, Haller H, Schiffer M (2011) The podocyte as a direct target of immunosuppressive agents. Nephrol Dial Transplant 26(1):18\u201324","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"3677_CR93","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1111\/j.1523-1755.2005.00723.x","volume":"68","author":"RF Ransom","year":"2005","unstructured":"Ransom RF, Lam NG, Hallett MA, Atkinson SJ, Smoyer WE (2005) Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization. Kidney Int 68(6):2473\u20132483","journal-title":"Kidney Int"},{"key":"3677_CR94","first-page":"326986","volume":"2013","author":"S Yu","year":"2013","unstructured":"Yu S, Li Y (2013) Dexamethasone inhibits podocyte apoptosis by stabilizing the PI3K\/Akt signal pathway. Biomed Res Int 2013:326986","journal-title":"Biomed Res Int"},{"key":"3677_CR95","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13075-015-0603-8","volume":"17","author":"T Fassbinder","year":"2015","unstructured":"Fassbinder T, Saunders U, Mickholz E, Jung E, Becker H, Schluter B, Jacobi AM (2015) Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus. Arthritis Res Ther 17:92","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"3677_CR96","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1182\/blood-2004-06-2410","volume":"105","author":"ME Lutsiak","year":"2005","unstructured":"Lutsiak ME, Semnani RT, De Pascalis R, Kashmiri SV, Schlom J, Sabzevari H (2005) Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide. Blood 105(7):2862\u20132868","journal-title":"Blood"},{"issue":"11","key":"3677_CR97","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1084\/jem.20040168","volume":"199","author":"BF Hoyer","year":"2004","unstructured":"Hoyer BF, Moser K, Hauser AE, Peddinghaus A, Voigt C, Eilat D, Radbruch A, Hiepe F, Manz RA (2004) Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB\/W mice. J Exp Med 199(11):1577\u20131584","journal-title":"J Exp Med"},{"issue":"11","key":"3677_CR98","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1177\/0961203312451784","volume":"21","author":"DK Moysiadis","year":"2012","unstructured":"Moysiadis DK, Perysinaki GS, Bertsias G, Stratakis S, Kyriacou K, Nakopoulou L, Boumpas DT, Daphnis E (2012) Early treatment with glucocorticoids or cyclophosphamide retains the slit diaphragm proteins nephrin and podocin in experimental lupus nephritis. Lupus 21(11):1196\u20131207","journal-title":"Lupus"},{"issue":"4","key":"3677_CR99","doi-asserted-by":"crossref","first-page":"e60784","DOI":"10.1371\/journal.pone.0060784","volume":"8","author":"R Vafadari","year":"2013","unstructured":"Vafadari R, Kraaijeveld R, Weimar W, Baan CC (2013) Tacrolimus inhibits NF-kappaB activation in peripheral human T cells. PLoS One 8(4):e60784","journal-title":"PLoS One"},{"key":"3677_CR100","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-016-0422-8","author":"G Liu","year":"2016","unstructured":"Liu G, Fan G, Guo G, Kang W, Wang D, Xu B, Zhao J (2016) FK506 attenuates the inflammation in rat spinal cord injury by inhibiting the activation of NF-kappaB in microglia cells. Cell Mol Neurobiol. doi: 10.1007\/s10571-016-0422-8","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"3677_CR101","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1042\/bst0240045","volume":"24","author":"PS Mattila","year":"1996","unstructured":"Mattila PS (1996) The actions of cyclosporin A and FK506 on T-lymphocyte activation. Biochem Soc Trans 24(1):45\u201349","journal-title":"Biochem Soc Trans"},{"issue":"10","key":"3677_CR102","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2215\/CJN.03180509","volume":"4","author":"SA De Serres","year":"2009","unstructured":"De Serres SA, Sayegh MH, Najafian N (2009) Immunosuppressive drugs and Tregs: a critical evaluation! Clin J Am Soc Nephrol 4(10):1661\u20131669","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"3677_CR103","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/cei.12604","volume":"180","author":"R De Bruyne","year":"2015","unstructured":"De Bruyne R, Bogaert D, De Ruyck N, Lambrecht BN, Van Winckel M, Gevaert P, Dullaers M (2015) Calcineurin inhibitors dampen humoral immunity by acting directly on naive B cells. Clin Exp Immunol 180(3):542\u2013550","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"3677_CR104","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2249.2009.04051.x","volume":"159","author":"S Heidt","year":"2010","unstructured":"Heidt S, Roelen DL, Eijsink C, Eikmans M, van Kooten C, Claas FH, Mulder A (2010) Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help. Clin Exp Immunol 159(2):199\u2013207","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"3677_CR105","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/ki.2010.269","volume":"78","author":"GH Struijk","year":"2010","unstructured":"Struijk GH, Minnee RC, Koch SD, Zwinderman AH, van Donselaar-van der Pant KA, Idu MM, ten Berge IJ, Bemelman FJ (2010) Maintenance immunosuppressive therapy with everolimus preserves humoral immune responses. Kidney Int 78(9):934\u2013940","journal-title":"Kidney Int"},{"issue":"9","key":"3677_CR106","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nm.1857","volume":"14","author":"C Faul","year":"2008","unstructured":"Faul C, Donnelly M, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, Chang JM, Choi HY, Campbell KN, Kim K, Reiser J, Mundel P (2008) The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 14(9):931\u2013938","journal-title":"Nat Med"},{"key":"3677_CR107","doi-asserted-by":"crossref","first-page":"32087","DOI":"10.1038\/srep32087","volume":"6","author":"X Shen","year":"2016","unstructured":"Shen X, Jiang H, Ying M, Xie Z, Li X, Wang H, Zhao J, Lin C, Wang Y, Feng S, Shen J, Weng C, Lin W, Wang H, Zhou Q, Bi Y, Li M, Wang L, Zhu T, Huang X, Lan HY, Zhou J, Chen J (2016) Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models. Sci Rep 6:32087","journal-title":"Sci Rep"},{"issue":"2","key":"3677_CR108","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/1470320314568520","volume":"16","author":"Y Shengyou","year":"2015","unstructured":"Shengyou Y, Li Y, Zhihong H, Yuanyuan M (2015) Influence of tacrolimus on podocyte injury inducted by angiotensin II. J Renin-Angiotensin-Aldosterone Syst 16(2):260\u2013266","journal-title":"J Renin-Angiotensin-Aldosterone Syst"},{"issue":"Suppl 1","key":"3677_CR109","doi-asserted-by":"crossref","first-page":"s2","DOI":"10.1191\/0961203305LU2109OA","volume":"14","author":"AC Allison","year":"2005","unstructured":"Allison AC (2005) Mechanisms of action of mycophenolate mofetil. Lupus 14[Suppl 1]:s2\u2013s8","journal-title":"Lupus"},{"issue":"7","key":"3677_CR110","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.4049\/jimmunol.1003319","volume":"187","author":"JL Karnell","year":"2011","unstructured":"Karnell JL, Karnell FG 3rd, Stephens GL, Rajan B, Morehouse C, Li Y, Swerdlow B, Wilson M, Goldbach-Mansky R, Groves C, Coyle AJ, Herbst R, Ettinger R (2011) Mycophenolic acid differentially impacts B cell function depending on the stage of differentiation. J Immunol 187(7):3603\u20133612","journal-title":"J Immunol"},{"issue":"10","key":"3677_CR111","first-page":"19781","volume":"8","author":"W Lv","year":"2015","unstructured":"Lv W, Lou J, Zhang Y, Lian P, Qi D, Wang J (2015) Mycophenolate mofetil inhibits hypertrophy and apoptosis of podocyte in vivo and in vitro. Int J Clin Exp Med 8(10):19781\u201319790","journal-title":"Int J Clin Exp Med"},{"issue":"8","key":"3677_CR112","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s00467-013-2529-1","volume":"29","author":"MJ Kemper","year":"2014","unstructured":"Kemper MJ, Lehnhardt A, Zawischa A, Oh J (2014) Is rituximab effective in childhood nephrotic syndrome? Yes and no. Pediatr Nephrol 29(8):1305\u20131311","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"3677_CR113","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.2215\/CJN.11941115","volume":"11","author":"CY Chan","year":"2016","unstructured":"Chan CY, Liu ID, Resontoc LP, Ng KH, Chan YH, Lau PY, Than M, Jordan SC, Lam KP, Yeo WS, Yap HK (2016) T lymphocyte activation markers as predictors of responsiveness to rituximab among patients with FSGS. Clin J Am Soc Nephrol 11(8):1360\u20131368","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"3677_CR114","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1002\/art.38107","volume":"65","author":"J Melet","year":"2013","unstructured":"Melet J, Mulleman D, Goupille P, Ribourtout B, Watier H, Thibault G (2013) Rituximab-induced T cell depletion in patients with rheumatoid arthritis: association with clinical response. Arthritis Rheum 65(11):2783\u20132790","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3677_CR115","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/art.30314","volume":"63","author":"FL Veerdonk van de","year":"2011","unstructured":"van de Veerdonk FL, Lauwerys B, Marijnissen RJ, Timmermans K, Di Padova F, Koenders MI, Gutierrez-Roelens I, Durez P, Netea MG, van der Meer JW, van den Berg WB, Joosten LA (2011) The anti-CD20 antibody rituximab reduces the Th17 cell response. Arthritis Rheum 63(6):1507\u20131516","journal-title":"Arthritis Rheum"},{"issue":"5","key":"3677_CR116","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/rheumatology\/keu487","volume":"54","author":"R Byng-Maddick","year":"2015","unstructured":"Byng-Maddick R, Ehrenstein MR (2015) The impact of biological therapy on regulatory T cells in rheumatoid arthritis. Rheumatology (Oxford) 54(5):768\u2013775","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"3677_CR117","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1053\/j.seminhematol.2010.01.011","volume":"47","author":"GJ Weiner","year":"2010","unstructured":"Weiner GJ (2010) Rituximab: mechanism of action. Semin Hematol 47(2):115\u2013123","journal-title":"Semin Hematol"},{"key":"3677_CR118","doi-asserted-by":"crossref","first-page":"973609","DOI":"10.1155\/2014\/973609","volume":"2014","author":"P Pateinakis","year":"2014","unstructured":"Pateinakis P, Pyrpasopoulou A (2014) CD20+ B cell depletion in systemic autoimmune diseases: common mechanism of inhibition or disease-specific effect on humoral immunity? Biomed Res Int 2014:973609","journal-title":"Biomed Res Int"},{"issue":"10","key":"3677_CR119","first-page":"5029","volume":"46","author":"TR Crook","year":"1986","unstructured":"Crook TR, Souhami RL, McLean AE (1986) Cytotoxicity, DNA cross-linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells. Cancer Res 46(10):5029\u20135034","journal-title":"Cancer Res"},{"issue":"8","key":"3677_CR120","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1172\/JCI200318384","volume":"111","author":"JS Maltzman","year":"2003","unstructured":"Maltzman JS, Koretzky GA (2003) Azathioprine: old drug, new actions. J Clin Invest 111(8):1122\u20131124","journal-title":"J Clin Invest"},{"issue":"4","key":"3677_CR121","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/art.38347","volume":"66","author":"P Eggleton","year":"2014","unstructured":"Eggleton P, Bremer E (2014) Direct and indirect rituximab-induced T cell depletion: comment on the article by Melet et Al. Arthritis Rheumatol 66(4):1053","journal-title":"Arthritis Rheumatol"},{"key":"3677_CR122","doi-asserted-by":"crossref","first-page":"4798639","DOI":"10.1155\/2016\/4798639","volume":"2016","author":"AJ Peired","year":"2016","unstructured":"Peired AJ, Sisti A, Romagnani P (2016) Mesenchymal stem cell-based therapy for kidney disease: a review of clinical evidence. Stem Cells Int 2016:4798639","journal-title":"Stem Cells Int"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-017-3677-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-017-3677-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-017-3677-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:45:21Z","timestamp":1750207521000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-017-3677-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,27]]},"references-count":122,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["3677"],"URL":"https:\/\/doi.org\/10.1007\/s00467-017-3677-5","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,27]]}}}